Explore more publications!

Texas Industry Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Texas Industry Journal.

Press releases published on October 8, 2025

Milton Arch Celebrates Milestone with Dallas NFT Headquarters Expansion
Wicked Oaks Festival - Halloween Event Austin Texas
HM&M Recognized as One of the Best Places to Work for Women
New Report Explores How Schools Can Close Interpreting Gaps
Contollo Consulting Launches ‘The Catalyst Effect’ Podcast to Empower Entrepreneurs and Drive Business Growth
Set Sale Marketing Launches Local SEO and Google Business Optimization Packages
ClickFunnels $99 for 3 Months Discount Promotion Opens for New Users to Slash Pricing
Tesla Outsourcing Services LLC Masters MEP Complexity, Engineering the Digital Heartbeat of Modern Buildings
Multicultural Pet Owners Offer Unique Opportunities for Brands, Retailers, and Pet Care Providers
Healthedly Insurance Services Named  Best Insurance Agency in Dallas
American Receivable Continues to Fuel Small Business Growth—Still Adding $2 Million in Monthly Funding After 46 Years
ANDRITZ and GESA Forge Strategic Partnership to Deliver Best-in-Class Generator Services Across North America
Puerta del Lobo Breaks Ground on Landmark Texas Winery and Luxury Development
ForteSG Unveils Fall 2025 Release of Forte with New Product Mix Reports and Scheduling Enhancements
New Construction Financing Products Empower More Buyers to Build Their Dream Homes in a Tight Housing Market
AMPP Names 2026–2028 Board Leadership and Vice Chair
The Village School Recognized Among Top Private Schools in America in 2025–2026 Niche Rankings
Stuff.io Taps Visionz Designs to Fuse Digital Media and Merch Into Next-Level Fan Experiences
Nilo Therapeutics se lanza con un financiamiento Serie A de 101 millones de dólares para avanzar una nueva clase de medicamentos dirigidos a los circuitos neuronales en enfermedades inmunológicas y nombra a Kim Seth como director ejecutivo
ナイロ・セラピューティクス (Nilo Therapeutics)、免疫疾患における神経回路を標的とする新しい種類の医薬品開発を推進するため、1億100万米ドル (約154億1,290万円) のシリーズA資金調達を実施し、キム・セス博士 (Kim Seth, Ph.D.) を最高経営責任者 (CEO) に任…

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions